发明名称 HIGH ACTIVITY GROWTH FACTOR MUTANTS
摘要 The invention relates to novel biosynthetic growth factor mutants which exhibit improved biological activity.
申请公布号 US2015057223(A1) 申请公布日期 2015.02.26
申请号 US201414182604 申请日期 2014.02.18
申请人 Biopharm Gesellschaft zur biotechnologischen Entwicklung von Pharmaka mbH 发明人 POHL Jens;PLOEGER Frank;KRUSE Michael
分类号 C07K14/495 主分类号 C07K14/495
代理机构 代理人
主权项 1. A method for promoting cartilage growth in a patient in need thereof, comprising administering to the patient an effective amount of a recombinant protein comprising an amino acid sequence at least 75% identical to the 102 amino acid cysteine-knot domain of GDF-5 or a fragment of said recombinant protein, wherein a) the amino acid at the position corresponding to methionine 453 (M453) of human wild-type GDF-5 (SEQ ID NO: 1) is alanine, valine or isoleucine, and/or b) the amino acid at the position corresponding to methionine 456 (M456) of human wild-type GDF-5 (SEQ ID NO: 1) is alanine, valine or isoleucine, and further wherein the recombinant protein or the fragment of said recombinant protein has an improved biological activity of at least 120% when compared to the mature GDF-5 protein.
地址 Heidelberg DE